KASCH HELMUT
No ORCID on file
· 15 papers in corpus
· active 1998
Frequent coauthors
- BERTRAM GUDRUN 15
- KURISCHKO ANATOLI 15
- MENZENBACH BERND 15
- PONSOLD KURT 15
- ROHRIG HEIDEMARIE 15
- SCHUBERT GERD 15
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …